Bioscience

Arizona Bioscience News: ASU tests cancer vaccine; UA studies Zika virus; Tucson surgeon to leave

May 19, 2016

By Amy Pitney

Women ScientistASU professor tests preventive cancer vaccine / Arizona Capitol Times

A cancer vaccine aimed at preventing all types of cancer, developed by a professor and a team of researchers at Arizona State University’s Biodesign Institute, has passed safety trials and is moving on to efficacy trials in dogs.

UA researchers working to predict spread of Zika virus / Arizona Daily Star

Researchers at the University of Arizona are using a federal grant to find out how long it takes the Zika virus to move from the gut of the Aedes aegypti mosquito to its salivary glands—knowledge needed to predict the potential for its spread.

Cancer Moonshot 2020: An important step towards cancer care / AZ Big Media (Op-ed)

Phoenix Children’s Hospital is taking a lead position in the pediatric consortium, whose primary mission is to advance bench-to-bedside translation of genomic technology to prevent, treat, and manage pediatric diseases, first in cancer and then in other conditions.

University of Arizona to lead study on asthma prevention in kids / KJZZ

UA will lead a $27 million nationwide study to test whether a naturopathic product developed in Europe could prevent chronic asthma in some children.

U of A entrepreneurs show their work to the public / Inside Tucson Business

TheraCea Pharma, a startup company developing therapeutic medicine for individuals suffering from neurological disorders, emerged from the McGuire Center, a part of UA’s Eller College of Management.

Giffords surgeon Peter Rhee leaving Tucson / Arizona Daily Star

Dr. Peter Rhee, the top trauma surgeon at Banner-University Medical Center Tucson, is leaving in June for a new job at the Grady Memorial Hospital in Atlanta. Read also: Banner loses ‘rock star’ surgeon in Tucson because of UA merger